Daily FNArena News - Australia
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | Technicals | Treasure ChestPrevious Stories
Will Westpac’s Relative Discount Close?
Nov 05 2019
Low interest rates, weak loan growth & wealth income are weighing on the major banks and brokers consider Westpac’s measures to shore up its balance sheet are prudent.
Infrastructure Growth Underpins Macquarie
Nov 04 2019
Is Macquarie Group simply being its usual conservative self, or are there real concerns about the ability to improve on the FY19 result?
Orica Poised For Better Year Ahead
Nov 04 2019
Brokers remain comfortable with the FY20 outlook provided by Orica but suspect the share price already reflects an earnings recovery.
FNArena Corporate Results Monitor – 04-11-2019
Nov 04 2019
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.
Can Institutional Banking Spur Growth At ANZ?
Nov 01 2019
ANZ Bank’s FY19 result confirmed the challenges faced by a banking sector that needs to find new areas of growth while grappling with narrowing interest margins.
Blackmores: Hopes Pinned On Restructuring
Nov 01 2019
Blackmores’ first half profit warning has sent analysts into a scramble to downgrade forecasts, but turnaround potential has been boosted by a shift in strategy.
Alacer Gold Promises More From Copler
Oct 31 2019
Alacer Gold’s oxide resource expansion at Copler holds significant promise while the sulphide plant pleased brokers with steady production throughout the September quarter.
Lovisa’s Expansion Captivates Brokers
Oct 30 2019
Jewellery retailer Lovisa Holdings continues to expand and invest in new markets, now operating 33 stores across the US, considered its main opportunity.
Retail Fuel Competition Still Dogs Viva Energy
Oct 29 2019
Despite higher refining margins, the focus is on Viva Energy’s retail fuel offering, which is likely to remain pressured by competition.
Will ResMed’s Growth Rates Taper?
Oct 28 2019
While ResMed has recovered its lead in the sleep disorder market, several brokers suspect stellar growth rates may taper.
Analyse The Market From A Different Angle
Latest News
| 1 |
TechnologyOne’s SaaS Transformation ‘Complete’Oct 07 2025 - Australia |
| 2 |
Stock Market in September RepublishOct 06 2025 - International |
| 3 |
Stock Market in SeptemberOct 06 2025 - International |
| 4 |
TechnologyOne Story by NoviOct 06 2025 - International |
| 5 |
Geopolitical Hedging Drives Investor Confidence in CommBankJun 12 2025 - General |